GMP production and testing of Xcellerated T Cells™ for the treatment of patients with CLL

References

• Hami LS, Ghana H, Yuan V, Craig S. Comparison of a static process and a bioreactor-based process for the GMP manufac-ture of autologous Xcellerated T Cells for clinical trials. Bioproc 2003;2:23— 34.
   Google Scholar
• June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990;11:211–6.
   PubMedGoogle Scholar
• Benoist C, Mathis D. T-lymphocyte differentiation and biology. In: Paul WE, editor. Fundamental Immunology. Philadelphia: Lippincott-Raven Publishers, 1999: 367–409.
   Google Scholar
• Pimental E. Interleukins and cytokines. In: Handbook of GrowthFactors. Boca Raton: CRC Press Inc, 1994: 53–79.
   Google Scholar
• Smith KA, Baker PE, Gillis S, Ruscetti FW. Functional and molecular characteristics of T-cell growth factor. Mol Immunol 1980;17:579— 89.
   PubMed Web of Science ®Google Scholar
• Smith KA. T-cell growth factor. Immunol Rev 1980;51:337–57.
   PubMed Web of Science ®Google Scholar
• Goldsmith M, Greene WC. Interleukin-2. In: Nicola NA, editor. Guidebook to Cytokines and their Receptors. Oxford: Oxford University Press, 1994: 27–30.
   Google Scholar
• Voss SD, Robb RJ. Interleukin-2 receptor. In: Nicola NA, editor. Guidebook to Cytokines and their Receptors. Oxford: Oxford University Press, 1994: 31–7.
   Google Scholar
• Grewal IS, Flavell RA. CD40 and CDI54 in cell mediated immunity. Annu Rev Immunol 1998;16: 1 1 1 — 35.
   Google Scholar
• Zhang M, Tracey KJ. Tumor necrosis factor. In: Thomson A, editor. The Cytokine Handbook, 3rd edition. London: Academic Press, 2000: 517–48.
   Google Scholar
• Everaus H, Luik E, Lehtmaa J. Active and indolent chronic lymphocytic leukaemia: immune and hormonal peculiarities. Cancer Immunol Immunother 1997;45:109— 14.
   PubMed Web of Science ®Google Scholar
• Kipps T, Castro E, Wierda W, Keating M et al. A phase I/II trialof Xcellerated T cells in patients with chronic lymphocytic leukemia. Blood 2003;102(1 I):p109a.
   Google Scholar
• Leshinsky N, Markham E, Lindgren R et al. Redirected lysis assay to measure cytolytic function of Xcellerated T cells and its correlation with induction of cytokines and upreg-ulation of cell surface markers. Cytotherapy 2002;4:484.
   Google Scholar
• Ferrand C, Robinet E, Contassot E et al. Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T-cell receptor beta chain hypervariable region repertoire. Hum Gene Ther 2000;11:1151–64.
   PubMed Web of Science ®Google Scholar
• Gorochov G, Neumann AU, Kereveur A et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nature Med 1998;4:215–21.
   PubMed Web of Science ®Google Scholar
• Green CL, Nolin L, Allison M et al. Four-color flow cytometricdetection of residual malignant B cells for lot release of Xcellerated T Ce115TM for infusion into patients with chronic lymphocytic leukemia. Cytotherapy 2004;6:417.
   Google Scholar
• Peggs KS, Verfuerth S, D'Sa S et al. Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation, Brit 7 Haematol 2003;120: 154–65.
   Google Scholar
• Mariani S, Coscia M, Even J et al. Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. Brit 7 Haematol 2001;113:1051— 9.
   PubMed Web of Science ®Google Scholar
• Roux E, Dumont-Girard F, Starobinski M et al. Recovery of immune reactivity after T-cell-depleted bone marrow trans-plantation depends on thymic activity. Blood 2000;96:2299— 303.
   PubMed Web of Science ®Google Scholar
• Claret EJ, Alyea EP, Orsini E et al. Characterization of T-cell repertoire in patients with graft-versus- leukemia after donor lymphocyte infusion. 7 Clin Invest 1997;100:855— 66.
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans HC, Kester MG, van deCorput L et al. Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. Blood 1998;91:4224— 31.
   Google Scholar
• Eyrich M, Croner T, Leiler C et al. Distinct contributions of CD4( ) and CD8( ) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following trans-plantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors. Blood 2002;100:1915— 8.
   PubMed Web of Science ®Google Scholar
• Gorski J, Yassai M, Zhu X et al. Circulating T-cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. 7 Immunol 1994;152: 5109— 19.
   Google Scholar
• Kuchroo VK, Anderson AC, Waldner H et al. T-cell response inexperimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T-cell repertoire. Annu Rev Immunol 2002;20:101–23.
   PubMed Web of Science ®Google Scholar
• Ria F, van den EP, Madakamutil LT et al. Molecular character-ization of the T-cell repertoire using immunoscope analysis and its possible implementation in clinical practice. Curr Mol Med 2001;1:297— 304.
   PubMedGoogle Scholar
• Vergelli M, Mazzanti B, Traggiai E et al. Short-term evolution ofautoreactive T-cell repertoire in multiple sclerosis. 7 Neurosci Res 2001;66: 517–24.
   Google Scholar
• Wong S, Wen L, Hibberd M et al. Analysis of the peripheral T-cell receptor V beta repertoire in newly diagnosed patients with type I diabetes. Autoimmunio 1994;18:77— 83.
   PubMed Web of Science ®Google Scholar
• Bernstein WB, Cox JH, Aronson NE et al. Immune reconstitu-tion following autologous transfers of CD3/CD28 stimulated CD4+ T cells to HIV-infected persons. Clinical Immunol 2004; in press.
   Google Scholar